Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.
Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics